Peter J. Francis, M.D., Ph.D.
Dr. Peter Francis received his medical degree from the University of Southampton in the United Kingdom and was trained as an ophthalmologist in London, specializing in inherited and acquired retinal diseases. He later earned his Ph.D. in molecular genetics working at the Institute of Ophthalmology in London, studying the genetic basis of congenital cataracts. While in London, he received numerous honors, including the National Research prize for “Best Up-and-Coming Medical Researcher in the UK” in 2002.
Dr. Francis completed several prestigious retina fellowships, in the United Kingdom and in the United States, including a joint fellowship at the Casey Eye Institute working with Dr. Michael Klein and Dr. Richard Weleber. In January of 2006, Dr. Francis returned to the Casey Eye Institute as a member of the faculty. His acceptance was made possible through a grant of ORDC Annual report 2007-2008 permanent US residency status on the basis of US National Interest in attracting clinical researchers.
As a faculty member at the Casey Eye Institute, Dr. Francis splits his time between clinical practice and basic science research. In clinic, sees patients with retinal degenerations and other inherited eye diseases, as well as acquired and age-related retinal diseases. He is involved in numerous clinical treatment trials for age-related macular degeneration, and is a Coinvestigator for the first-ever phase II clinical treatment trial for retinitis pigmentosa, with enrollment beginning later this year.
Dr. Francis is the current recipient of Career Development Awards from the Foundation Fighting Blindness and Research to Prevent Blindness to support his work in the study of inherited retinal disease. He serves as the co-director of the Oregon Retinal Degeneration Center, and is a leader in the area of stem cell transplantation. He has been instrumental in the planning, design, and conduct of all of our current clinical trials and has a growing consultative practice in Ophthalmic Genetics, concentrating on retinal degenerations and allied disorders.